The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...
Cleaning up after a flood can be time-consuming and confronting. It can also be risky. Here’s what to keep in mind when you ...
Humans have an exceptional ability to deal with viruses. In most cases, your immune system is able to fight an infection. On ...
Spectrum Brands Holdings, Inc. (NYSE:SPB), a diversified consumer products company with annual revenue of $2.96 billion, has been navigating a complex market environment with a mix of opportunities ...
LUBBOCK, Texas- Mosquitoes are often more than just an annoying part of summer nights, they can be deadly for pets, ...
A man is now convicted for starting two wildfires in 2024, one of them forcing thousands in El Dorado County to evacuate from ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Great design is more than aesthetics—it shapes the way we live, interact, and experience the world. The European Product ...
While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...
Despite the constant presence of mosquitoes, the risk of disease transmission fluctuates throughout the year between high and low risk months.
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results